| LINE ITEM (USD / %) | FY 2025
FILED 2025-07-31 | FY 2024
FILED 2024-07-31 | FY 2023
FILED 2023-07-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.20B | $980.5M | $905.3M |
| YoY Revenue Growth % | +22.6% | +8.3% | — |
| Gross Profit | $752.1M | $583.4M | — |
| Gross Margin % | 62.5% | 59.5% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $41.1M | -$52.6M | -$149.5M |
| Operating Margin % | 3.4% | -5.4% | -16.5% |
| Net Income (GAAP) | $0 | $0 | $0 |
| EBITDA (Normalized) | $45.7M | -$47.5M | -$116.9M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $300.9M | $195.7M | $38.4M |
| Capital Expenditures (CapEx) | $5.7M | $6.4M | $40.7M |
| Free Cash Flow (FCF) | $295.1M | $189.4M | -$2.3M |
| FCF Margin % | 24.5% | 19.3% | -0.3% |
| Return on Invested Capital (ROIC %) | 2.0% | -3.6% | -2.7% |
| Cash & Short-Term Equivalents | $407.9M | $697.5M | — |
| Total Debt (Short + Long Term) | $531.5M | $573.3M | $1.69B |
| Total Stockholders' Equity | $1.51B | $1.27B | $3.46B |